Suppr超能文献

带 cuff 的中心静脉导管进行血液透析的充分性

Adequacy of haemodialysis with cuffed central-vein catheters.

作者信息

Atherikul K, Schwab S J, Conlon P J

机构信息

Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.

出版信息

Nephrol Dial Transplant. 1998 Mar;13(3):745-9. doi: 10.1093/ndt/13.3.745.

Abstract

UNLABELLED

Cuffed central-venous haemodialysis catheters are emerging as an alternative permanent haemodialysis vascular access. There is limited data regarding the adequacy of dialysis with prolonged used of these catheters. We conducted a prospective study comparing three commonly used cuffed central-venous haemodialysis catheters: (1) PermCath, Quinton Instrument Co, Seattle; (2) Tesio, Med Comp, Inc, Harleysville PA; (3) VasCath Soft Cell, Bard Instrument Company, Toronto, and compared them with control patients dialysing with arteriovenous access (AV) access. We randomly assigned 64 patients who needed prolonged temporary vascular access to placement of one of three catheters. The control group comprised 222 patients dialysing simultaneously in the same units with AV access.

METHODS

All patients were dialysed with identical machines and kidneys. Maximal effort were made with every catheter to optimize achievable blood flow. Catheters with mechanical problems were treated first with urokinase and then fibrin sheath catheter stripping. The mean blood flow was determined by averaging mean blood flows from 30 consecutive treatments. Reliability of catheter was defined as percentage of treatments that were performed at a median blood flow of 350 ml/min or above during these 30 treatments. Kt/V was measured monthly and calculated using the single-pool Daugirdas formula. Haemodialysis prescription were adjusted for Kt/V above 1.2. Recirculation was measured using two-needle low-blood-flow technique.

RESULTS

The mean blood flows were (PermCath 383.6 ml/min, Tesio 396.3 ml/min, VasCath 320.4 ml/min). PermCath and Tesio had comparable mean blood flows and were significantly higher than VasCath (P<0.005). Reliability of catheters were (PermCath 86.9%, Tesio 81.6%, VasCath 42.3%). Tesio and PermCath were equally reliable and both were more reliable than VasCath (P<0.005). Had the target for reliability been 300 ml/min all three catheters would have been equally reliable. Negative arterial pressure in excess of 300 mmHg prevented faster blood flows in 98% of instances. None of the catheters performed as well as the control population with AV access (mean blood flow 437ml/min, reliability 96%, P<0.005). Recirculation rates were 3.7% for PermCath 3.9% for Tesio, and 4% for VasCath. All patients weighing less than 85 kg acheived a Kt/V of 1.2 with a 4-h treatment. For comparison purposes when Kt/V was normalized to a 70-kg patient the results were PermCath 1.42. Tesio 1.44, VasCath 1.19, AV access 1.64.

SUMMARY

All three catheters are capable of providing adequate haemodialysis although large patients will need extended treatment times. The PermCath and Tesio provide blood flow and reliability superior to the VasCath. Blood flow is limited in all catheters by inflow, as evidenced by negative arterial pressure. All catheters had acceptable recirculation. AV access is superior in terms of blood flow and reliability to all tested catheters.

摘要

未加标签

带 cuff 的中心静脉血液透析导管正逐渐成为一种永久性血液透析血管通路的替代选择。关于长期使用这些导管进行透析的充分性的数据有限。我们进行了一项前瞻性研究,比较三种常用的带 cuff 的中心静脉血液透析导管:(1)PermCath,Quinton 仪器公司,西雅图;(2)Tesio,Med Comp 公司,宾夕法尼亚州哈雷斯维尔;(3)VasCath Soft Cell,巴德仪器公司,多伦多,并将它们与使用动静脉通路(AV)进行透析的对照患者进行比较。我们将 64 名需要长期临时血管通路的患者随机分配至三种导管之一的置入。对照组包括 222 名在同一单位同时使用 AV 通路进行透析的患者。

方法

所有患者均使用相同的机器和肾脏进行透析。对每根导管都尽最大努力优化可达到的血流量。有机械问题的导管首先用尿激酶治疗,然后进行纤维蛋白鞘导管剥离。平均血流量通过对连续 30 次治疗的平均血流量进行平均来确定。导管的可靠性定义为在这 30 次治疗期间,以中位数血流量 350 毫升/分钟或以上进行的治疗的百分比。每月测量 Kt/V,并使用单池 Daugirdas 公式计算。血液透析处方根据 Kt/V 高于 1.2 进行调整。使用双针低血流量技术测量再循环。

结果

平均血流量分别为(PermCath 383.6 毫升/分钟,Tesio 396.3 毫升/分钟,VasCath 320.4 毫升/分钟)。PermCath 和 Tesio 的平均血流量相当,且显著高于 VasCath(P<0.005)。导管的可靠性分别为(PermCath 86.9%,Tesio 81.6%,VasCath 42.3%)。Tesio 和 PermCath 同样可靠,且两者都比 VasCath 更可靠(P<0.005)。如果可靠性目标为 300 毫升/分钟,所有三种导管都会同样可靠。超过 300 毫米汞柱的负动脉压在 98%的情况下阻止了更快的血流量。没有一种导管的表现能与使用 AV 通路的对照人群一样好(平均血流量 437 毫升/分钟,可靠性 96%,P<0.005)。PermCath 的再循环率为 3.7%,Tesio 为 3.9%,VasCath 为 4%。所有体重小于 85 千克的患者通过 4 小时治疗实现了 Kt/V 为 1.2。为了进行比较,当将 Kt/V 标准化为 70 千克的患者时,结果为 PermCath 1.42,Tesio 1.44,VasCath 1.19,AV 通路 1.64。

总结

所有三种导管都能够提供充分的血液透析,尽管体型较大的患者需要延长治疗时间。PermCath 和 Tesio 在血流量和可靠性方面优于 VasCath。如负动脉压所示,所有导管的血流量都受到流入的限制。所有导管的再循环都可接受。在血流量和可靠性方面,AV 通路优于所有测试导管。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验